
Kyoto University Graduate School of Medicine, Medical Innovation Center

Protein 3D Structure Modeling

Osaka Office
Transparency builds trust.
Information on Fumihisa Kojima’s companies, research, businesses, and related projects is organized in an easy-to-review format.

Studio Makyu Co., Ltd.
Business and Corporate Positioning.
The companies, positions, joint research, overseas entities, and related projects associated with Fumihisa Kojima are organized in one place. It provides a clear overview of the positioning of each initiative, including Biozipcode Inc., Studio Makyu Co., Ltd., Senard Co., Ltd., GDT, and the Overseas Expansion Business.

Shiga University of Medical Science Joint Research Laboratory
Public Materials & Reference Links.
Company profiles, joint research with universities, papers, patents, press releases, business introductions, and related websites are compiled as materials that can be reviewed externally. Information related to Biozipcode Inc. research, Biozipcode™ technology, GDT, 5-ALA, and overseas expansion is organized so that it can be reviewed as needed.

Palau Blockchain Summit
Medical, Investment & Other Disclaimers.
This page summarizes important notes regarding medical research, 5-ALA, Biozipcode™, GDT, global medical expansion, and other related information published on this site. It does not guarantee medical efficacy, business participation, regulatory approval, or clinical trial results, and requires review by specialists in each field.
This site is intended to provide information on Fumihisa Kojima’s activities, affiliated companies, R&D, and related projects, and does not solicit or invite investments, deposits, loans, investment funds, or similar funds from the general public.

5-ALA: 5-Aminolevulinic Acid
